Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Funding linked to late-stage clinical asset transaction The post Pinwheel Thera...
Launch follows FDA approval for ANDA The post Lupin launches Topiramate Extend...
The designation covers adults with phosphatidylinositol-4,5-bisphosphate 3-kinas...
Approval covers 5 mg and 10 mg strengths for US market The post Zydus receives...
Samsung Biologics is set to become part of CEPI’s Vaccine Manufacturing Facility...
CM Yogi Adityanath sets out policy framework, law and order measures, and pharm...
Approval based on phase III MATTERHORN study supports perioperative use The pos...
Three-year partnership marks Sun Pharma’s first cricket sponsorship The post Su...
With friendshoring gaining attention in global supply chain conversations, this...
The deal grants Genentech exclusive global rights to develop and commercialise t...
The therapy aims to treat Type I allergic reactions, including anaphylaxis, in p...
Sun Pharma Advanced Research Company (SPARC) announced that the United States ...
Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 10...
India's Foremost Pharma & Biotech Magazine ~ Friendshoring: Pharma's Next Suppl...
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, anno...
The initiative aims to speed up the development of platform-based genetic therap...